A Phase II Trial of Trisenox Plus Thalomid as Treatment in Patients With Myelodysplastic Syndrome

Clinical trial NCT00251511 · TERMINATED

Trial details

NCT number: NCT00251511
Sponsor: Veeda Oncology
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome

Start date: 2004-08-01
Primary completion: 2006-01-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.